Delivery Order SPE2DB22D2206-SPE2DB24FJV20
Award Date
8/16/24
Potential Completion Date
8/19/24
Potential Value
$4.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,647.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, to support military treatment programs and facilities. The award has an ultimate completion date of September 30, 2024, and is a Firm Fixed Price Delivery Order contract. There is no set-aside designation mentioned in the information provided....
This federal contract award, valued at $4,876.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. The contract has an ultimate completion date of September 19, 2024 and is a Firm Fixed Price Delivery Order. This award is not associated with a set-aside program. As a supplier to various government agencies, Amerisourcebergen holds several...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier to the U.S. government. The $4,647.12 firm fixed-price delivery order is for 4,564,437,255 units of the MONOVISC 88 MG/4 ML SYRINGE 4ML product, with a completion date of April 30, 2024. The contract has no set-aside designation. Amerisourcebergen, a subsidiary of the larger Cencora, Inc. parent company, holds a significant...
This federal contract award, valued at $4,647.12, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical supply product, with a completion date of June 10, 2024. This award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, which has a total potential value of up to $999,999,999.00 through December...
The U.S. Defense Logistics Agency (DLA) awarded a $5,268.40 firm fixed-price delivery order to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of 4,565,285,746 units of the MONOVISC 88 MG/4 ML SYRINGE 4ML medical product. This delivery order was issued under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $4,647.12 firm-fixed-price delivery order is for the supply of 4,566,077,237 units of the pharmaceutical product MONOVISC 88 MG/4 ML SYRINGE 4ML. The award has an ultimate completion date of October 11, 2024 and is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $9,719.73 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,564,804,524 units of the MONOVISC 88 MG/4 ML SYRINGE 4ML pharmaceutical product. This Delivery Order contract has a firm fixed price and an ultimate completion date of June 5, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the...
This federal contract award, valued at $4,647.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...
This federal contract award, valued at $4,906.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 19, 2024. The contract does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,426,393 units of the MONOVISC 88 MG/4 ML SYRINGE 4ML product. The award is a Firm Fixed Price Delivery Order, valued at $4,906.14, with an ultimate completion date of August 13, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to...